Table 2. Patient and tumour characteristics of NSCLCS analysed for EGFR mutation and gene copy number.
| Characteristics | Patients (%) |
|---|---|
| Total | 84 |
| UICC stage | |
| I–IIIA | 20 (23.8) |
| IIIB–IV | 58 (69.0) |
| Recurrence | 5 (6.0) |
| No information | 1 (1.2) |
| Cancer type | |
| NSCLC, NOS | 26 (31.0) |
| AC | 51 (60.7) |
| SCC | 6 (7.1) |
| LCNEC | 1 (1.2) |
AC=adenocarcinoma; EGFR=epidermal growth factor receptor; LCNEC=large cell neuroendocrine carcinoma; NSCLC, NOS=non-small-cell lung carcinoma, not otherwise specified; SCC=squamous cell carcinoma; UICC=International Union Against Cancer.